Intestinal Microbiota Transplant (IMT) Capsules

DRUG2 trials

Sponsors

Nanjing Medical University, Virginia Commonwealth University

Conditions

Alcohol Use DisorderCardiopulmonary BypassCardiovascular DiseaseCirrhosisLiver Disease; Alcohol-Related

Phase 1

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Active, not recruitingNCT05548452

Virginia Commonwealth UniversityAlcohol Use Disorder, Cirrhosis, Liver Disease; Alcohol-Related

Start: 2022-11-21End: 2027-11-01Target: 80Updated: 2026-08-24

Unknown Phase

Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)

Enrolling by invitationNCT04444362

Nanjing Medical UniversityCardiopulmonary Bypass, Cardiovascular Disease

Start: 2025-01-01End: 2026-12-31Target: 500Updated: 2026-01-06